Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Open Access
- 7 August 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 15 (18), 2743-2751
- https://doi.org/10.1093/hmg/ddl210
Abstract
Huntington's disease (HD) is a progressive neurodegenerative disorder for which only symptomatic treatments of limited effectiveness are available. Preventing early misfolding steps and thereby aggregation of the polyglutamine (polyQ)-containing protein huntingtin (htt) in neurons of patients may represent an attractive therapeutic strategy to postpone the onset and progression of HD. Here, we demonstrate that the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) potently inhibits the aggregation of mutant htt exon 1 protein in a dose-dependent manner. Dot-blot assays and atomic force microscopy studies revealed that EGCG modulates misfolding and oligomerization of mutant htt exon 1 protein in vitro, indicating that it interferes with very early events in the aggregation process. Also, EGCG significantly reduced polyQ-mediated htt protein aggregation and cytotoxicity in an yeast model of HD. When EGCG was fed to transgenic HD flies overexpressing a pathogenic htt exon 1 protein, photoreceptor degeneration and motor function improved. These results indicate that modulators of htt exon 1 misfolding and oligomerization like EGCG are likely to reduce polyQ-mediated toxicity in vivo. Our studies may provide the basis for the development of a novel pharmacotherapy for HD and related polyQ disorders.Keywords
This publication has 31 references indexed in Scilit:
- Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesisNeurology, 2006
- Normal huntingtin function: an alternative approach to Huntington's diseaseNature Reviews Neuroscience, 2005
- Development of a Human Light Chain Variable Domain (VL) Intracellular Antibody Specific for the Amino Terminus of Huntingtin via Yeast Surface DisplayJournal of Molecular Biology, 2004
- The hunt for huntingtin function: interaction partners tell many different storiesTrends in Biochemical Sciences, 2003
- A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in DrosophilaNature Genetics, 2002
- Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapyProceedings of the National Academy of Sciences of the United States of America, 2000
- Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's DiseaseCell, 2000
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Neuropathological Classification of Huntingtonʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1985